Cover Image
市場調查報告書

全球生物檢驗市場

Global Bio-detection Market 2014-2018

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 322811
出版日期 內容資訊 英文 63 Pages
訂單完成後即時交付
價格
Back to Top
全球生物檢驗市場 Global Bio-detection Market 2014-2018
出版日期: 2015年01月07日 內容資訊: 英文 63 Pages
簡介

生物檢驗系統,是將病原體和病毒等的生物學性刺激轉換為電力信號的分析設備。生物檢驗市場,從2014年到2018年之間,預計以14.19%的年複合成長率擴大。這個成長的主要原因之一,是生物恐怖行動攻擊的威脅。

本報告提供全球生物檢驗市場現狀與今後的預測調查、各技術及各地區趨勢、市場成長因素與課題、主要企業分析等。

第1章 摘要整理

第2章 簡稱清單

第3章 調查範圍

  • 市場概要
  • 主要的產品

第4章 市場調查手法

  • 市場調查流程
  • 調查手法

第5章 簡介

第6章 市場形勢

  • 市場概要
    • 生物檢驗系統的產品生命週期
  • 市場規模與預測
  • 波特的五力分析

第7章 各技術的市場區隔

  • 各全球技術世代的生物檢驗市場
    • 第1代
    • 第2代
    • 第3代

第8章 地理區隔

  • 全球各地區的生物檢驗市場
    • 南北美洲的生物檢驗市場
    • 歐洲、中東、非洲地區的生物檢驗市場
    • 亞太地區的生物檢驗市場

第9章 市場魅力

第10章 購買標準

第11章 市場成長因素

第12章 成長因素與其影響

第13章 市場課題

第14章 成長因素與課題的影響

第15章 市場趨勢

第16章 趨勢與其影響

第17章 業者情勢

  • 競爭模式
    • Agilent Technologies
    • Cepheid
    • Roche Diagnostics
    • Smiths Detection
  • 其他卓越供應商

第18章 主要供應商分析

  • Agilent Technologies
  • Cepheid
  • Roche Diagnostics
  • Smiths Detection

第19章 主要前提條件

第20章 相關報告

目錄
Product Code: IRTNTR4409

About Bio-detection

Bio-detection has emerged as a solution to the public and governments. With an increase in bio-terrorism, the occurrence of illness and deaths is very frequent. This event is caused by the airborne chemicals or pathogens that are released by a terrorist or a group of people or even by an individual for a motive. These pathogens can be detected by a system called bio-detection, which signals the entry or the existence of a virus. The increasing attacks have brought a major concern to the public as well as governments. Attacks such as the 2001 Anthrax scare, the 2003 severe acute respiratory syndrome (SARS), the 2004 Ricin letters, the 2009 H1N1, and the 2014 Ebola outbreaks have driven governments to increase their bio-surveillance budgets.

TechNavio's analysts forecast the Global Bio-detection market to grow at a CAGR of 14.19 percent over the period 2013-2018.

Covered in this Report

This report covers the present scenario and the growth prospects of the Global Bio-detection market for the period 2014-2018. To calculate the market size, the report considers the revenue generated from the sales, services, and upgrades of the bio-detection system in the Government sector.

The bio-detection systems considered in this report are listed below:

  • 1st generation bio-detection systems
  • 2nd generation bio-detection systems
  • 3rd generation bio-detection systems

TechNavio's report, the Global Bio-detection Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the APAC and EMEA region; it also covers the Global Bio-detection market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Key Regions

  • Americas
  • APAC
  • EMEA

Key Vendors

  • Agilent Technologies
  • Cepheid
  • Roche Diagnostics
  • Smiths Group

Other Prominent Vendors

  • 20/20 GeneSystems
  • 3M Microbiology
  • Advnt Biotechnologies
  • Alexeter Technologies
  • ANP Technologies
  • BAS - Biological Alarm Systems
  • BD Biosciences Immunocytometry Systems
  • Bertin Technologies
  • Biodefense
  • BioDETECT
  • BioSentinel Pharmaceuticals
  • BioTraces
  • BioVeris
  • Commonwealth Biotechnologies
  • Dycor Technologies
  • Environics
  • Evogen
  • General Dynamics Canada
  • GenPrime
  • Groton Biosystems
  • Haztech Systems
  • JMAR Technologies
  • New Horizons Diagnostics
  • Proengin
  • Response Biomedical
  • Tetracore

Market Driver

  • Need for Early Detection System for Bio-terrorist Attacks
  • For a full, detailed list, view our report

Market Challenge

  • Difficulties in Detecting Minute Presence of Pathogens
  • For a full, detailed list, view our report

Market Trend

  • Increased Need for Biosecurity
  • For a full, detailed list, view our report

Key Questions Answered in this Report

  • What will the market size be in 2018 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

Table of Contents

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

  • 03.1. Market Overview
  • 03.2. Product Offerings

04. Market Research Methodology

  • 04.1. Market Research Process
  • 04.2. Research Methodology

05. Introduction

06. Market Landscape

  • 06.1. Market Overview

Product Lifecycle of Bio-detection Systems

  • 06.2. Market Size and Forecast
  • 06.3. Five Forces Analysis

07. Market Segmentation by Technology

  • 07.1. Global Bio-detection Market by Technology Generation
  • 07.2. Global Bio-detection Market by Technology 2013-2018
    • 07.2.1. Global 1st Generation Bio-detection Market
    • 07.2.2. Global 2nd Generation Bio-detection Market
    • 07.2.3. Global 3rd Generation Bio-detection Market

08. Geographical Segmentation

  • 08.1. Global Bio-detection Market by Geographical Segmentation 2013
  • 08.2. Global Bio-detection Market by Geographical Segmentation 2013-2018
  • 08.3. Global Bio-detection Market by Geographical Segmentation 2013-2018
    • 08.3.1. Bio-Detection Market in the Americas
    • 08.3.2. Bio-Detection Market in the EMEA Region
    • 08.3.3. Bio-Detection Market in the APAC Region

09. Market Attractiveness

  • 09.1. Market Attractiveness by Geographical Segmentation

10. Buying Criteria

11. Market Growth Drivers

12. Drivers and their Impact

13. Market Challenges

14. Impact of Drivers and Challenges

15. Market Trends

16. Trends and their Impact

17. Vendor Landscape

  • 17.1. Competitive Scenario
    • 17.1.1. Agilent Technologies
    • 17.1.2. Cepheid
    • 17.1.3. Roche Diagnostics
    • 17.1.4. Smiths Detection
  • 17.2. Other Prominent Vendors

18. Key Vendor Analysis

  • 18.1. Agilent Technologies
    • 18.1.1. Key Facts
    • 18.1.2. Business Overview
    • 18.1.3. Business Segmentation by Revenue 2013
    • 18.1.4. Business Segmentation by Revenue 2012 and 2013
    • 18.1.5. Geographical Segmentation by Revenue 2013
    • 18.1.6. Business Strategy
    • 18.1.7. Recent Developments
    • 18.1.8. SWOT Analysis
  • 18.2. Cepheid
    • 18.2.1. Key Facts
    • 18.2.2. Business Overview
    • 18.2.3. Business Segmentation
    • 18.2.4. Business Segmentation by Revenue 2012 and 2013
    • 18.2.5. Geographical Segmentation by Revenue 2013
    • 18.2.6. Business Strategy
    • 18.2.7. Recent Developments
    • 18.2.8. SWOT Analysis
  • 18.3. Roche Diagnostics
    • 18.3.1. Key Facts
    • 18.3.2. Business Overview
    • 18.3.3. Business Segmentation by Revenue 2013
    • 18.3.4. Geographical Segmentation by Revenue 2013
    • 18.3.5. Business Strategy
    • 18.3.6. Recent Developments
    • 18.3.7. SWOT Analysis
  • 18.4. Smiths Detection
    • 18.4.1. Key Facts
    • 18.4.2. Business Overview
    • 18.4.3. Products and Solutions
    • 18.4.4. Service and Support
    • 18.4.5. Technologies
    • 18.4.6. Business Strategy
    • 18.4.7. Recent Developments
    • 18.4.8. SWOT Analysis

19. Key Assumptions

20. Other Reports in this Series

List of Exhibits

  • Exhibit 1: Market Research Methodology
  • Exhibit 2: Product Lifecycle of Bio-detection Systems
  • Exhibit 3: Global Bio-detection Market 2013-2018 (US$ billion)
  • Exhibit 4: Global Bio-detection Market by Technology Generation 2013-2018
  • Exhibit 5: Global Bio-detection Market by Technology 2013-2018 (US$ billion)
  • Exhibit 6: Global Bio-detection market by Geographical Segmentation 2013
  • Exhibit 7: Global Bio-detection Market by Geographical Segmentation 2013-2018 (percentage)
  • Exhibit 8: Global Bio-detection Market by Geographical Segmentation 2013-2018 (US$ billion)
  • Exhibit 9: Agilent Technologies: Business Segmentation by Revenue 2013
  • Exhibit 10: Agilent Technologies: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
  • Exhibit 11: Agilent Technologies: Geographical Segmentation by Revenue 2013
  • Exhibit 12: Cepheid: Business Segmentation 2013
  • Exhibit 13: Cepheid: Business Segmentation by Revenue 2012 and 2013 (US$ million)
  • Exhibit 14: Cepheid: Geographical Segmentation by Revenue 2013
  • Exhibit 15: Roche Diagnostics: Business Segmentation by Revenue 2013
  • Exhibit 16: Roche Diagnostics: Geographical Segmentation by Revenue 2013
  • Exhibit 17: Smiths Detection: Products and Solutions
  • Exhibit 18: Smiths Detection: Service and Support
  • Exhibit 19: Smiths Detection: Technologies
Back to Top